A

Amneal Pharmaceuticals
D

AMRX

7.84500
USD
-0.04
(-0.44%)
مغلق
حجم التداول
69,332
الربح لكل سهم
1
العائد الربحي
-
P/E
-9
حجم السوق
2,430,729,553
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    BMY
    BMY
    0.050
    (0.09%)
    55.840 USD
    GILD
    GILD
    -0.140
    (-0.13%)
    109.920 USD
    GSK
    GSK
    -0.320
    (-0.87%)
    36.650 USD
    MRK
    MRK
    1.820
    (2.08%)
    89.500 USD
    PFE
    PFE
    0.405
    (1.56%)
    26.305 USD
    TEVA
    TEVA
    -0.255
    (-1.50%)
    16.745 USD
    المزيد
الأخبار
المقالات

العنوان: Amneal Pharmaceuticals

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targetingthe central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.